- Medicenna Therapeutics Corp MDNA11 Clinical Update Call TranscriptAug 09, 2023
- Medicenna Therapeutics Corp at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Medicenna Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Medicenna Therapeutics Corp at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 09, 2023
- Q3 2023 Medicenna Therapeutics Corp Earnings Call TranscriptFeb 07, 2023$0.751 (-1.83%)Earnings
- Q2 2023 Medicenna Therapeutics Corp Earnings Call TranscriptNov 04, 2022$0.646 (-3.15%)Earnings
- Medicenna Therapeutics Corp Annual Shareholders Meeting TranscriptSep 21, 2022
- Q1 2023 Medicenna Therapeutics Corp Earnings Call TranscriptAug 15, 2022$0.98 (-8.41%)Earnings
- Q4 2022 Medicenna Therapeutics Corp Earnings Call TranscriptJun 22, 2022$0.9755 (+15.31%)Earnings
- Medicenna Therapeutics Corp at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 02, 2022
- Q3 2022 Medicenna Therapeutics Corp Earnings Call TranscriptFeb 09, 2022$1.87 (+1.08%)Earnings
- Q2 2022 Medicenna Therapeutics Corp Earnings Call TranscriptNov 12, 2021$2.05 (+0.74%)Earnings
- Medicenna Therapeutics Corp Annual Shareholders Meeting TranscriptSep 23, 2021
- Medicenna Therapeutics Corp at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Q1 2022 Medicenna Therapeutics Corp Earnings Call TranscriptAug 13, 2021$2.04 (-6.42%)Earnings
- Medicenna Therapeutics Corp MDNA11 Program Update Call TranscriptJul 27, 2021
- Q4 2021 Medicenna Therapeutics Corp Earnings Call TranscriptMay 28, 2021$3.89 (+1.83%)Earnings
- Medicenna Therapeutics Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Medicenna Therapeutics Corp. - Special Call TranscriptDec 11, 2020
- Medicenna Therapeutics Corp. - Special Call TranscriptMar 25, 2020
- Medicenna Therapeutics Corp to Host Key Opinion Leader Call Focused on Latest MDNA55 Recurrent Glioblastoma Phase 2b Clinical Study Results TranscriptNov 25, 2019
Medicenna Therapeutics Corp. - Special Call Transcript
Good afternoon, and welcome to the Medicenna KOL webinar on MDNA55 for the treatment of recurrent glioblastoma multiforme. (Operator Instructions) As a reminder, this webinar is being recorded, and a replay will be made available on the Medicenna website following the event. .
I would now like to turn the call over to your host, Dr. Fahar Merchant, President and Chief Executive Officer of Medicenna. Please go ahead, Doctor.
Thank you, operator. Good morning, everyone, and welcome to today's key opinion leader event. Before I begin, I would like to remind everyone that during the presentations and the Q&A session to follow, forward-looking statements may be made as disclosed on this slide.
Next slide, please. I would also like to thank our key opinion leaders, Dr. David Reardon, Dr. John Sampson; Dr. Ruthie Davi, and Dr. Amy McKee, for graciously taking the time to join us on the webcast today.
Next slide, please. So today's event will focus on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)